Cargando…
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Aging is by far the most prominent risk factor for Alzheimer's disease (AD), and both aging and AD are associated with apparent metabolic alterations. As developing effective therapeutic interventions to treat AD is clearly in urgent need, the impact of modulating whole-body and intracellular m...
Autores principales: | Austad, Steven N., Ballinger, Scott, Buford, Thomas W., Carter, Christy S., Smith, Daniel L., Darley-Usmar, Victor, Zhang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897048/ https://www.ncbi.nlm.nih.gov/pubmed/35256932 http://dx.doi.org/10.1016/j.apsb.2021.06.014 |
Ejemplares similares
-
A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: Implications for their use as bioenergetic biomarkers()
por: Kramer, Philip A., et al.
Publicado: (2014) -
Mitochondrially targeted compounds and their impact on cellular bioenergetics()
por: Reily, Colin, et al.
Publicado: (2013) -
The Bioenergetic Health Index: a new concept in mitochondrial
translational research
por: Chacko, Balu K., et al.
Publicado: (2014) -
The Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative Diseases
por: Redmann, Matthew, et al.
Publicado: (2016) -
Distinct Effects of Rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on Cellular Bioenergetics and Cell Death
por: Giordano, Samantha, et al.
Publicado: (2012)